Halea Meese
Overview
Explore the profile of Halea Meese including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mould-Millman N, Dixon J, Lee M, Meese H, Mata L, Burkholder T, et al.
Health Sci Rep
. 2021 Oct;
4(4):e422.
PMID: 34693030
Background And Aims: Improving the quality of pre-hospital traumatic shock care, especially in low- and middle-income countries, is particularly relevant to reducing the large global burden of disease from injury....
2.
Martin A, Raja A, Meese H
Int J Emerg Med
. 2021 May;
14(1):26.
PMID: 33931010
No abstract available.
3.
Gutman C, Dorfman D, Meese H, Kavanagh P, Koyama A
J Womens Health (Larchmt)
. 2020 Feb;
29(5):622-626.
PMID: 32074475
Contraception use reduces teen pregnancy, and long-acting reversible contraception is recommended as first-line treatment. Since many adolescents use the emergency department (ED) as a primary source of health care, it...
4.
You C, Meese H, Stephenson A, Montieth A, Ma L, Hernandez M, et al.
Ocul Immunol Inflamm
. 2018 Sep;
27(7):1165-1173.
PMID: 30207810
: To review early withdrawal of immunomodulatory therapy (IMT) for birdshot retinochoroidopathy (BSRC). : Retrospective case-series of sixteen patients with Human-leukocyte-antigen-A29-positive BSRC treated with IMT ≥ 1 year and discontinued...
5.
Mould-Millman N, Meese H, Alattas I, Ido M, Yi I, Oyewumi T, et al.
Prehosp Emerg Care
. 2018 Mar;
22(6):734-742.
PMID: 29596006
Objective: Strokes are a leading cause of morbidity and mortality in the United States, especially in the "stroke belt" of the southeast. Up to 65% of stroke patients access care...
6.
Lasave A, You C, Ma L, Abusamra K, Lamba N, Valdes Navarro M, et al.
Retina
. 2017 Feb;
38(2):395-402.
PMID: 28225369
Purpose: To assess long-term effectiveness of rituximab therapy for refractory noninfectious uveitis affecting the posterior segment. Methods: Retrospective case series. Patients diagnosed with recalcitrant noninfectious posterior uveitis who were treated...
7.
Maleki A, Sahawneh H, Ma L, Meese H, He Y, Foster C
Retina
. 2016 Sep;
37(5):836-843.
PMID: 27681002
Purpose: To examine the efficacy and safety of infliximab therapy in the treatment for noninfectious intermediate uveitis resistant to conventional immunomodulatory therapy. Methods: Forty-four eyes of 23 patients with resistant...
8.
Castiblanco C, Meese H, Foster C
J AAPOS
. 2016 Apr;
20(2):145-7.
PMID: 27079596
Purpose: To evaluate adalimumab therapy in children with uveitis. Methods: The electronic health records of pediatric patients diagnosed with uveitis and treated with adalimumab therapy were reviewed retrospectively. Demographic information,...
9.
Oray M, Meese H, Foster C
Expert Rev Clin Immunol
. 2016 Apr;
12(8):827-37.
PMID: 27055583
Scleritis is an inflammatory process of the sclera and adjacent tissues with a wide spectrum of clinical presentations and co-morbidities. Careful clinical history taking, detailed ocular examination, and appropriate investigation...
10.
Maleki A, Meese H, Sahawneh H, Foster C
Expert Rev Clin Immunol
. 2016 Mar;
12(7):775-86.
PMID: 26972783
Uveitis is the third most common cause of blindness in developed countries. Considering the systemic and local complications of long-term corticosteroid therapy and the intolerance due to side effects and...